Skip to main content

Table 4 Changes in blood BNP, LVEDD, and LVEF in the high BNP group

From: Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels

Parameters Dobutamine (n = 30) rhBNP (n = 28)
  Baseline 5 Days Changes Baseline 5 Days Changes
BNP (pg/mL) 1890 ± 742 1261 ± 560** 629 ± 715 1819 ± 665 843 ± 450**ΔΔ 976 ± 566Δ
LVEDD (mm) 63.8 ± 4.6 61.2 ± 6.5** 2.6 ± 4.3 64.3 ± 4.9 60.9 ± 5.7** 3.3 ± 3.2
LVEF (%) 32.1 ± 6.1 39.6 ± 10.9** 7.5 ± 8.1 31.3 ± 6.8 43.7 ± 11.2** 12.4 ± 7.5Δ
  1. Abbreviations: LVEDD left ventricle end diastolic dimension, LVEF left ventricular ejection fraction, Other abbreviations are same as in Table 2. Values are mean ± SD. **P < 0.01 (paired t- test) versus baseline; ΔP < 0.05, ΔΔP < 0.01 (unpaired t- test) versus dobutamine.